Apr. 7, 2022—Vanderbilt research found parents who are reluctant to vaccinate their children against the flu are more than five times as likely to decline the COVID-19 vaccine for their children.
Feb. 24, 2022—A Vanderbilt study will explore the neurologic and psychiatric complications of flu and evaluate adverse effects of the antiviral treatment oseltamivir, also known by the brand name Tamiflu.
Jan. 27, 2022—by Christina Echegaray Before the current rise in flu cases in Middle Tennessee, a group of doctors and nurses at Monroe Carell Jr. Children’s Hospital at Vanderbilt set out in the fall to protect children from flu before it ever arrived. The team, led by pediatrician Elizabeth Williams, MD, MPH, dubbed its project “The Mobile...
Dec. 22, 2021—Flu season is in full swing, and as health care professionals, we strive to keep ourselves, our patients and our community members safe and healthy. By receiving your flu vaccine, you support our goal in promoting a healthier community. As a reminder, VUMC faculty and staff are required to meet compliance requirements for flu vaccination...
Sep. 24, 2020—Infectious diseases specialist Thomas Talbot, MD, MPH, chief hospital epidemiologist at Vanderbilt University Medical Center, answers questions about the rapidly approaching U.S. flu season and how it might play into the COVID-19 pandemic.
Aug. 10, 2020—In 2011 Vanderbilt University Medical Center received worldwide attention for doubling the Guinness World Record for the number of flu shots given in an 8-hour period, making its annual flu vaccine event, Flulapalooza, a model for others to follow.
Dec. 11, 2019—‘Tis the season for colds, flu and upper respiratory illnesses say health care providers at Monroe Carell Jr. Children's Hospital at Vanderbilt.
Oct. 9, 2019—Vanderbilt University Medical Center is leading a multicenter national study to evaluate the effectiveness of the influenza vaccine for preventing the flu’s most serious side effects — admission to an intensive care unit (ICU), organ failure and death.
May. 16, 2019—Researchers at Vanderbilt University Medical Center and the Scripps Research Institute have discovered a “hidden target” on the surface of the hypervariable influenza A virus that could lead to better ways to prevent and treat the flu.